ZELIRA

Welcome to the Brand page for “ZELIRA”, which is offered here for Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of alpha-one proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections;conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of alpha-one proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections;.

Its status is currently believed to be active. Its class is unavailable. “ZELIRA” is believed to be currently owned by “ZELIRA THERAPEUTICS LIMITED”.